Judith Baumeister

New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease

Gerald Kleymann, Rüdiger Fischer, Ulrich A. K. Betz et al. · Nature Medicine · 2002 · 326 citations

Drug Candidates, Medicine, Antiviral Drug Development +10

<i>In</i> <i>Vitro</i> and <i>In Vivo</i> Activities of the Novel Anticytomegalovirus Compound AIC246

Peter Lischka, Guy Hewlett, Tobias Wunberg et al. · Antimicrobial Agents and Chemotherapy · 2010 · 237 citations · Full text

Vitro Inhibitory Activity, Antiviral Compound, Medicine +11

Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs

Hans Ulrichts, Karen Silence, Anne Schoolmeester et al. · Blood · 2011 · 178 citations · Full text

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Maarten Van Roy, Cedric Ververken, Els Beirnaert et al. · Arthritis Research & Therapy · 2015 · 176 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +10

Pre-Clinical Intravenous Serum Pharmacokinetics of Albumin Binding and Non-Half-Life Extended Nanobodies®

Sven Hoefman, Ingrid Ottevaere, Judith Baumeister et al. · Antibodies · 2015 · 115 citations · Full text

Albumin Binding, Nanomedicine, Translational Medicine +14